Article
EGFR mutation detection by microfluidic technology: a validation study.
Journal of clinical pathology - 1 Nov 2013
Malapelle Umberto, Russo Stefania, Pepe Francesco, Sgariglia Roberta, De Luca Caterina, Bellevicine Claudio, Pallante Pierlorenzo, Troncone Giancarlo
Abstract excerpt
Advanced non-small cell lung cancer samples are tested for epidermal growth factor receptor (EGFR) gene mutations. Their detection by direct sequencing is time-consuming. Conversely, the length analysis of fluorescently labelled PCR products is easier. To avoid labelled primers and the automated capillary electrophoresis apparatus, we validated a fast and sensitive chip-based microfluidic technology. The limit of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
